Literature DB >> 28278079

Breast carcinoma associated with prolactinoma: A case report.

Yurong Zheng1, Wenju Mo1, Yang Yu1, Dehong Zou1, Xiangming He1, Xianghou Xia1, Jiejie Hu1.   

Abstract

We report a 28-year-old woman who presented with a 6-year history of milk-like discharge from both of her nipples and was diagnosed with prolactinoma based on computed tomography (CT) findings and serum prolactin level. Further breast examination revealed a mass located in the upper outer region of the left breast. She underwent subtotal pituitary tumor resection. Thereafter, modified radical mastectomy was performed for left breast cancer. Twelve years after treatment, prolactinoma recurrence was detected, and bromocriptine therapy was administered. No recurrence of breast cancer was discovered. Based on this case report, we stress the importance of prolactin levels due to their possible biologic effects on breast cancer induction or growth.

Entities:  

Keywords:  Breast cancer; bromocriptine; prolactin; prolactinoma

Mesh:

Year:  2017        PMID: 28278079      PMCID: PMC5389425          DOI: 10.1080/15384047.2017.1294284

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  23 in total

1.  Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience.

Authors:  J M Bhatavdekar; D D Patel; H H Vora; N G Shah; P R Chikhlikar; N Ghosh
Journal:  Head Neck       Date:  2000-05       Impact factor: 3.147

Review 2.  Acromegaly due to an ectopic pituitary adenoma in the clivus: case report and review of literature.

Authors:  Julia Goulart Appel; Marvin Bergsneider; Harry Vinters; Noriko Salamon; Marilene B Wang; Anthony P Heaney
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

3.  Prolactin stimulates prostate cell proliferation by increasing endoplasmic reticulum content due to SERCA 2b over-expression.

Authors:  Alexandre Crépin; Gabriel Bidaux; Fabien Vanden-Abeele; Etienne Dewailly; Vincent Goffin; Natalia Prevarskaya; Christian Slomianny
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

4.  Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.

Authors:  A J Vomachka; S L Pratt; J A Lockefeer; N D Horseman
Journal:  Oncogene       Date:  2000-02-21       Impact factor: 9.867

Review 5.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

Review 6.  The global breast cancer burden.

Authors:  John R Benson; Ismail Jatoi
Journal:  Future Oncol       Date:  2012-06       Impact factor: 3.404

7.  PRL modulates cell cycle regulators in mammary tumor epithelial cells.

Authors:  Matthew D Schroeder; Jaime Symowicz; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2002-01

8.  Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.

Authors:  Kathleen A O'Leary; Michael P Shea; Linda A Schuler
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

9.  Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos.

Authors:  Jennifer H Gutzman; Sarah E Nikolai; Debra E Rugowski; Jyoti J Watters; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2005-03-03

10.  Giant prolactinoma: case report and review of literature.

Authors:  Masoud Rahmanian; Hamidreza Aghaei Meybodi; Bagher Larijani; Mohammad-Reza Mohajeri-Tehrani
Journal:  J Diabetes Metab Disord       Date:  2013-01-08
View more
  2 in total

Review 1.  Breast Cancer and Prolactin - New Mechanisms and Models.

Authors:  Charles V Clevenger; Hallgeir Rui
Journal:  Endocrinology       Date:  2022-10-01       Impact factor: 5.051

2.  Giant prolactinoma, germline BRCA1 mutation, and depression: a case report.

Authors:  Rita Bettencourt-Silva; Joana Queirós; Josué Pereira; Davide Carvalho
Journal:  J Med Case Rep       Date:  2018-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.